Taylor Mitchell
Physician Assistant · Colorado Springs, CONPI 1730753302
Payments from drug & device makers
Across 136 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$461
- AbbVie$438
- Novo Nordisk$365
- AstraZeneca$153
- Amgen$132
- Boehringer Ingelheim$127
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,711100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 28 | $461 |
| AbbVie | 22 | $438 |
| Novo Nordisk | 17 | $365 |
| AstraZeneca | 9 | $153 |
| Amgen(2 entities) | 3 | $132 |
| Boehringer Ingelheim | 5 | $127 |
| Lilly USA, LLC | 6 | $103 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $98 |
| Aytu Biopharma, Inc. | 4 | $73 |
| Exact Sciences | 4 | $67 |
| Boston Scientific | 3 | $66 |
| Seqirus USA Inc | 3 | $65 |
| Inspire Medical Systems, Inc. | 1 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Lucid Diagnostics Inc. | 2 | $47 |
| Grifols USA, LLC | 2 | $43 |
| Astellas Pharma US Inc | 2 | $39 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Merck | 1 | $23 |
| Pulmonx Corporation | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| Abbott | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$2,711 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $15,547 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $697 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $376 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $360 |
| Pregabalin | 20 | $339 |
| Losartan Potassium | 24 | $274 |
| Levothyroxine Sodium | 37 | $234 |
| Atorvastatin Calcium | 41 | $229 |
| Lisinopril | 44 | $207 |
| Amlodipine Besylate | 21 | $162 |
| Sertraline Hcl | 16 | $120 |
| Montelukast Sodium | 12 | $113 |
| Oxycodone Hcl | 13 | $112 |
| Metformin Hcl | 14 | $107 |
| Clonazepam | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $461 | $15,54720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Colorado Springs
- Miyoko GreenColorado Springs$16K
- Toni BoykoColorado Springs$12K
- Dominique SwainColorado Springs$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.